Covance Scientists to Present at the Molecular Med Tri-Con - California
www.biomarkerscommons.org - "Scientists from Covance Discovery and Translational Services will be showcasing their company's R&D capabilities, talent and technologies in biomarkers, discovery services, genomics and proteomics to over 3,000 participants at the 2012 Molecular Med Tri-Con this week in San Francisco, California USA.
"The Molecular Med Tri-Con is a unique conference that brings together the therapeutic and diagnostic aspects of the life sciences industry in one place with access to over 3,000 delegates from 1,200 companies. Spanning five days (Sun 2/19 – Thurs 2/23), the event includes 12 core programs, 450+ presentations, 60+ posters and 140+ exhibitors.
"Covance Discovery and Translational Services, which integrates the company's Antibody Products, Biomarker Center of Excellence, Discovery Services, Genomics Laboratory and Immunology Services, was created in 2010 to offer clients a depth and breadth of drug discovery and biomarker services unmatched in the CRO industry.
"Scientists from the Biomarker Center of Excellence, Discovery Services, the Covance Genomics Laboratory and Antibody Products will be available at the conference to discuss the company's spectrum of services and expertise, including Covance's new BioPathways resource, which enables scientists to search biological and disease pathways and rapidly identify validated assays and commercially available antibodies."
Click here for full article.
There's a glimmer of hope seen in a new optimism among employers